National Health Investors Inc. (NYSE:NHI)’s share price hit a new 52-week high during trading on Monday . The company traded as high as $80.47 and last traded at $80.44, with a volume of 165,895 shares traded. The stock had previously closed at $79.65.

A number of equities analysts recently commented on NHI shares. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $77.00 target price for the company in a research note on Wednesday, April 27th. Cantor Fitzgerald started coverage on shares of National Health Investors in a research note on Thursday, June 23rd. They set a “hold” rating and a $70.00 target price for the company. JMP Securities restated a “hold” rating on shares of National Health Investors in a research note on Saturday, June 4th. Finally, Mizuho upped their price objective on shares of National Health Investors from $66.00 to $77.00 and gave the company a “neutral” rating in a research note on Monday, August 8th. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. National Health Investors currently has an average rating of “Hold” and an average target price of $72.50.

The company’s 50 day moving average price is $77.70 and its 200 day moving average price is $69.43. The firm has a market capitalization of $3.15 billion and a price-to-earnings ratio of 18.528.

National Health Investors (NYSE:NHI) last issued its earnings results on Friday, August 5th. The real estate investment trust reported $1.22 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.01. The business earned $61.20 million during the quarter, compared to analysts’ expectations of $58.08 million. The business’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.17 EPS. Equities analysts anticipate that National Health Investors Inc. will post $4.87 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 10th. Stockholders of record on Friday, September 30th will be paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.52%. The ex-dividend date is Wednesday, September 28th.

In related news, insider Kristin Sallee Gaines sold 4,044 shares of National Health Investors stock in a transaction on Tuesday, June 28th. The shares were sold at an average price of $73.71, for a total transaction of $298,083.24. Following the sale, the insider now owns 53,089 shares of the company’s stock, valued at approximately $3,913,190.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert A. Mccabe, Jr. sold 1,250 shares of National Health Investors stock in a transaction on Monday, June 13th. The stock was sold at an average price of $71.61, for a total transaction of $89,512.50. Following the sale, the director now directly owns 9,736 shares in the company, valued at approximately $697,194.96. The disclosure for this sale can be found here.

An institutional investor recently raised its position in National Health Investors stock. Westfield Capital Management Co. LP boosted its stake in National Health Investors Inc. (NYSE:NHI) by 81.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 436,425 shares of the real estate investment trust’s stock after buying an additional 195,807 shares during the period. Westfield Capital Management Co. LP owned about 1.16% of National Health Investors worth $26,565,000 at the end of the most recent quarter.

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.